Lipocine Inc. (LPCN)
Nasdaq: LPCN · Pharmaceutical Preparations · Salt Lake City, US · filing with the SEC since 2011
Who runs Lipocine Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Patel Mahesh V.
Chief Executive Officer. First filing Aug 2013, latest Jun 30, 2026, 17 filings in all.
Officers reporting now
2
of 6 people with a filing in the last fifteen months
Directors reporting now
4
13 people on the record since 2013
Officerssales are open-market, Oct 1, 2025 to Oct 1, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Patel Mahesh V. | Chief Executive Officer | Aug 2013 | Jun 30, 2026 | none |
| Fogarty Krista | Principal Accounting Officer | Jan 2022 | Dec 19, 2025 | none |
Directorssales are open-market, Oct 1, 2025 to Oct 1, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Higuchi John W. | director | Aug 2013 | Oct 1, 2026 | none |
| Grissinger Michael | director | Aug 2026 | Aug 7, 2026 | none |
| Jene Jill M. | director | Apr 2022 | Jun 4, 2026 | none |
| Ono Richard Dana | director | Jan 2014 | Jun 4, 2026 | none |
Earlier names on the record7, newest filing first
Fink Jeffrey Arvin · director · last filing Jun 2025Papapetropoulos Spyros · director · last filing Jun 2025Nomikos George · officer · last filing Nov 2022Brown Morgan R · officer · last filing Dec 2021Hill Stephen A · director · last filing Dec 2020Bass Gregory Brooks · officer · last filing Jan 2018Mattila Jyrki · officer · last filing Jan 2017
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.